Bloomberg Law reports today that Siemens is evaluating a spinoff of a majority stake in its Siemens Healthineers unit.
The report says that the large German conglomerate engaged potential advisors to discuss exit options for its 71% ownership in Siemens Healthineers. It cites people familiar with the matter who requested to remain anonymous. The report also claims Siemens may consider distributing shares to its investors as a dividend.
Siemens shares rose nearly 2% to $137.58 apiece on the back of the report early this morning. Shares of Siemens Healthineers, however, fell slightly, dipping 0.6% to $26.90 in the early morning.
Siemens Healthineers currently stands as the world’s fourth-largest medtech company, bringing in more than $24 billion in annual revenue.
(MDO’s Medtech Big 100 Special Report takes a deep look at the world’s 100 largest medical device companies, including Siemens Healthineers. Visit here for a free download.)
Late last year, German media reported that Siemens intended to evaluate economic opportunities in the healthcare space and then determine the need to retain the Healthineers business as an investment. Siemens CFO Ralf Thomas expected the deliberations to wrap up by a capital market day at the end of this year.
Meanwhile, Siemens Healthineers continues to plug along, inking recent surgical robotics collaborations with Stryker and Interventional Systems, as well as an MRI suite collaboration with Cook Medical.
